David Brandon MD
- Department of Radiology and Imaging Sciences
Associate Professor
- (404) 712-4843
- david.brandon@emoryhealthcare.org
Overview
Dr. Brandon is a Nuclear Medicine physician who is active in nuclear medicine education and clinical quality improvement, serving as Program Director of Emorys nuclear medicine residency and nuclear radiology fellowship since 2011. He is currently Membership Chair for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in addition to serving on multiple committees, previously chairing the Young Professionals Committee, and coauthoring society clinical guidelines. In addition to speaking nationally, he has organized multiple national meeting sessions.
Academic Appointment
- Assistant Professor, Emory University
Education
Degrees
- MD from Baylor College of Medicine
- BA from Baylor University (graduated in the Honors Program)
Research
Focus
- My current research focus is two pronged. The first evalautes the clinical utlity of multiple software platforms for interpreting FDG PET brain images. Second, I am about to begin work with a multidisciplinary team evaluating an investigational radiopharmaceutical targeting CXCR4 expression in head and neck cancer.
Publications
-
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Eur J Nucl Med Mol Imaging Volume: 50 Page(s): 1743 - 1752
05/01/2023 Authors: Kokabi N; Arndt-Webster L; Chen B; Brandon D; Sethi I; Davarpanahfakhr A; Galt J; Elsayed M; Bercu Z; Cristescu M -
Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
Cardiovasc Intervent Radiol Volume: 46 Page(s): 60 - 68
01/01/2023 Authors: Webster LA; Villalobos A; Cheng B; Xing M; Majdalany BS; Bercu ZL; Cristescu MM; Brandon D; Schuster D; Baum Y -
Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
J Vasc Interv Radiol Volume: 33 Page(s): 1578 - 1587.e5
12/01/2022 Authors: Kokabi N; Webster LA; Elsayed M; Switchenko JM; Chen B; Brandon D; Galt J; Sethi I; Cristescu M; Kappadath SC -
Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study.
Cancers (Basel) Volume: 13
09/29/2021 Authors: Sankhla T; Cheng B; Nezami N; Xing M; Sethi I; Bercu Z; Brandon D; Majdalany B; Schuster DM; Kokabi N -
Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
Cardiovasc Intervent Radiol Volume: 44 Page(s): 1194 - 1203
08/01/2021 Authors: Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N -
Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond.
World J Gastrointest Oncol Volume: 13 Page(s): 440 - 452
05/15/2021 Authors: Elsayed M; Loya M; Galt J; Schuster DM; Bercu ZL; Newsome J; Brandon D; Benenati S; Behbahani K; Duszak R -
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
J Vasc Interv Radiol Volume: 32 Page(s): 752 - 760
05/01/2021 Authors: Villalobos A; Cheng B; Wagstaff W; Sethi I; Bercu Z; Schuster DM; Brandon DC; Galt J; Kokabi N -
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer.
Nucl Med Commun Volume: 42 Page(s): 402 - 409
04/01/2021 Authors: Cheng B; Sethi I; Davisson N; Brandon D; Barron B; Galt J; Bercu Z; Schuster DM; Kokabi N -
Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Cardiovasc Intervent Radiol Volume: 44 Page(s): 254 - 260
02/01/2021 Authors: Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N -
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma.
Laryngoscope Volume: 130 Page(s): E850 - E857
12/01/2020 Authors: Qian DC; Magliocca KR; Aiken AH; Baugnon KL; Brandon DC; Stokes WA; McDonald MW; Patel MR; Baddour HM; Kaka AS